Belongs to

• Center for Hematologic Malignancies

Types of Work

["2019"]

[[["Meeting Abstracts",1548],["Journal Articles",1430],["Reviews",91],["Editorials",39],["Book Sections",38],["Research Letters",33],["Guidelines",16],["Conference Papers",14],["Correspondences",7],["Miscellaneous",2],["Books Whole",1]]]

[3219]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• humans
• male
• nonhuman
• priority journal

Recent Works

1. Dasatinib/prednisone induction followed by blinatumomab/ dasatinib in Ph(+) acute lymphoblastic leukemia

   Journal Article

   Advani, A. S.; Moseley, A.; O’Dwyer, K. M.; Wood, B. L.; Park, J.; Wieduwilt, M.; Jeyakumar, D.; Yaghmour, G.; Atallah, E. L.; Gerds, A. T.; more...
   Blood Advances (2023)

   Fulltext@MSK | Save
2. DNA polymerase θ protects leukemia cells from metabolically induced DNA damage

   Journal Article

   Vekariya, U.; Toma, M.; Nieborowska-Skorska, M.; Le, B. V.; Caron, M. C.; Kukuyan, A. M.; Sullivan-Reed, K.; Podszywalow-Bartnicka, P.; Chitrala, K. N.; Atkins, J.; more...
   Blood (2023)

   Fulltext@MSK | Save
3. Therapeutic targeting of PRAME with m(TCR)CAR T cells in acute myeloid leukemia

   Journal Article

   Kirkey, D. C.; Loeb, A. M.; Castro, S.; McKay, C. N.; Perkins, L.; Pardo, L.; Leonti, A. R.; Tang, T. T.; Loken, M. R.; Brodersen, L. E.; more...
   Blood Advances (2023)

   Fulltext@MSK | Save